The Use of Chemotherapy in Metastatic Breast Cancer
- 1 December 1989
- journal article
- clinical trial
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 3 (4) , 807-821
- https://doi.org/10.1016/s0889-8588(18)30532-x
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Is cisplatin useful for breast cancer?European Journal of Cancer and Clinical Oncology, 1987
- An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancerBreast Cancer Research and Treatment, 1985
- Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatmentBreast Cancer Research and Treatment, 1985
- Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancerPublished by Elsevier ,1980
- Cancer of the BreastNew England Journal of Medicine, 1980
- Adriamycin in combination for the treatment of breast cancer.A southwest oncology group studyCancer, 1978